Literature DB >> 11001575

Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed.

D E Thrall1, G L Rosner, C Azuma, S M Larue, B C Case, T Samulski, M W Dewhirst.   

Abstract

A randomized study was designed in dogs with spontaneous soft tissue sarcomas to gain information about the relationship between hyperthermia dose and outcome. The study compared two levels of thermal dose applied to dogs with heatable tumours, so it was necessary to deliver either a low (2-5 CEM 43 degrees C T90) or high (20-50 CEM 43 degrees C T90) thermal dose as precisely as possible. It was also desirable to have similar numbers of hyperthermia treatments in each thermal dose group. Identification of heatable tumours and randomization to high or low heat dose group was done during the first hyperthermia treatment. This was readily accomplished using mapping of temperatures in thermometry catheters, manual recording of thermal data, and visual inspection of raw thermal data with subsequent adjustment of the duration of the hyperthermia treatment. An analysis of precision of thermal dose delivery was conducted after approximately 50% of projected accrual had been met in a randomized phase III assessment of thermal dose effect. Fifty-four dogs were eligible for randomization; in 48 dogs the tumour was deemed heatable according to predetermined temperature criteria applied during the first heat treatment. Twenty-four dogs were randomized to the high heat dose group, and 24 to the low heat dose group. Median (range) total thermal dose for dogs in the high dose group was 43.5 CEM 43 degrees C T90 (16.4-66.6) compared to 3.2 CEM 43 degrees C T90 (2.1-4.6) for dogs in the low dose group. There was no overlap of thermal doses between groups. Thus, thermal dose could be delivered accurately, being within the predetermined range in 47 of the 48 dogs. Thermal dose quantified as CEM 43 degrees C T50, however, did overlap between groups and the clinical significance of this finding will not be known until outcome data are analysed. Most dogs in both groups received five hyperthermia treatments. Median (range) treatment duration for dogs in the high dose group was 300 min (147-692) compared to III min (51-381) for dogs in the low dose group. Relatively simple but accurate methods of delivering prescribed thermal dose as described herein will aid the translation of clinical hyperthermia from the research setting into more general practice once the characteristics of the relationship between hyperthermia dose and outcome are understood.

Entities:  

Mesh:

Year:  2000        PMID: 11001575     DOI: 10.1080/026567300416712

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  13 in total

1.  Fast ultrasound beam prediction for linear and regular two-dimensional arrays.

Authors:  Mario Hlawitschka; Robert J McGough; Katherine W Ferrara; Dustin E Kruse
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2011-09       Impact factor: 2.725

2.  Minimum-time thermal dose control of thermal therapies.

Authors:  Dhiraj Arora; Mikhail Skliar; Robert B Roemer
Journal:  IEEE Trans Biomed Eng       Date:  2005-02       Impact factor: 4.538

Review 3.  Hyperthermia: How Can It Be Used?

Authors:  Zhaleh Behrouzkia; Zahra Joveini; Behnaz Keshavarzi; Nazila Eyvazzadeh; Reza Zohdi Aghdam
Journal:  Oman Med J       Date:  2016-03

4.  Thermal dose fractionation affects tumour physiological response.

Authors:  Donald E Thrall; Paolo Maccarini; Paul Stauffer; James Macfall; Marlene Hauck; Stacey Snyder; Beth Case; Keith Linder; Lan Lan; Linda McCall; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

5.  Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.

Authors:  Marwan Moussa; S Nahum Goldberg; Gaurav Kumar; Tatyana Levchenko; Vladimir Torchilin; Muneeb Ahmed
Journal:  Int J Hyperthermia       Date:  2016-09-06       Impact factor: 3.914

6.  Magnetomotive Optical Coherence Elastography for Magnetic Hyperthermia Dosimetry Based on Dynamic Tissue Biomechanics.

Authors:  Pin-Chieh Huang; Paritosh Pande; Adeel Ahmad; Marina Marjanovic; Darold R Spillman; Boris Odintsov; Stephen A Boppart
Journal:  IEEE J Sel Top Quantum Electron       Date:  2015-12-17       Impact factor: 4.544

7.  Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy.

Authors:  Donald E Thrall; Susan M LaRue; Daohai Yu; Thaddeus Samulski; Linda Sanders; Beth Case; Gary Rosner; Chieko Azuma; Jeannie Poulson; Amy F Pruitt; Wilma Stanley; Marlene L Hauck; Laurel Williams; Paul Hess; Mark W Dewhirst
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

8.  Feasibility of concurrent treatment with the scanning ultrasound reflector linear array system (SURLAS) and the helical tomotherapy system.

Authors:  José A Peñagarícano; Eduardo Moros; Petr Novák; Yulong Yan; Peter Corry
Journal:  Int J Hyperthermia       Date:  2008-08       Impact factor: 3.914

9.  Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers.

Authors:  Bin Xie; Ravi Singh; F M Torti; Pawel Keblinski; Suzy Torti
Journal:  Phys Med Biol       Date:  2012-09-05       Impact factor: 3.609

Review 10.  Magnetic Resonance Imaging-Guided Breast Interventions: Role in Biopsy Targeting and Lumpectomies.

Authors:  Eva C Gombos; Jayender Jagadeesan; Danielle M Richman; Daniel F Kacher
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-07-08       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.